These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 36990962)

  • 1. Who is lost to follow-up in HIV care? Assessment of care retention over time and the impact of COVID-19. Longitudinal analysis of the PISCIS cohort.
    Palacio-Vieira J; Moreno-Fornés S; Díaz Y; Aceitón J; Bruguera A; Nomah DK; Llibre JM; Knobel H; Chivite I; Miro JM; Domingo P; Suanzes P; Fanjul F; Navarro G; Macorigh L; Mera A; Casabona J; Imaz A; Reyes-Urueña J;
    HIV Med; 2023 Sep; 24(9):965-978. PubMed ID: 36990962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective assessment of loss to follow-up: incidence and associated factors in a cohort of HIV-positive adults in rural Tanzania.
    Kalinjuma AV; Glass TR; Weisser M; Myeya SJ; Kasuga B; Kisung'a Y; Sikalengo G; Katende A; Battegay M; Vanobberghen F;
    J Int AIDS Soc; 2020 Mar; 23(3):e25460. PubMed ID: 32128998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Same-day antiretroviral therapy is associated with increased loss to follow-up in South African public health facilities: a prospective cohort study of patients diagnosed with HIV.
    Joseph Davey D; Kehoe K; Serrao C; Prins M; Mkhize N; Hlophe K; Sejake S; Malone T
    J Int AIDS Soc; 2020 Jun; 23(6):e25529. PubMed ID: 32510186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of loss to follow-up among HIV positive patients receiving antiretroviral therapy in a test and treat setting: A retrospective cohort study in Masaka, Uganda.
    Kiwanuka J; Mukulu Waila J; Muhindo Kahungu M; Kitonsa J; Kiwanuka N
    PLoS One; 2020; 15(4):e0217606. PubMed ID: 32255796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival probability and factors associated with time to loss to follow-up and mortality among patients on antiretroviral treatment in central Kenya.
    Wekesa P; McLigeyo A; Owuor K; Mwangi J; Ngugi E
    BMC Infect Dis; 2022 Jun; 22(1):522. PubMed ID: 35668350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss to follow-up before and after initiation of antiretroviral therapy in HIV facilities in Lilongwe, Malawi.
    Tweya H; Oboho IK; Gugsa ST; Phiri S; Rambiki E; Banda R; Mwafilaso J; Munthali C; Gupta S; Bateganya M; Maida A
    PLoS One; 2018; 13(1):e0188488. PubMed ID: 29373574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with attrition, mortality, and loss to follow up after antiretroviral therapy initiation: data from an HIV cohort study in India.
    Alvarez-Uria G; Naik PK; Pakam R; Midde M
    Glob Health Action; 2013 Sep; 6():21682. PubMed ID: 24028937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re-engagement in care of people living with HIV lost to follow-up after initiation of antiretroviral therapy in Mali: Who returns to care?
    Baldé A; Lièvre L; Maiga AI; Diallo F; Maiga IA; Costagliola D; Abgrall S
    PLoS One; 2020; 15(9):e0238687. PubMed ID: 32911516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss to follow-up in "test and treat era" and its predictors among HIV-positive adults receiving ART in Northwest Ethiopia: Institution-based cohort study.
    Bantie B; Seid A; Kerebeh G; Alebel A; Dessie G
    Front Public Health; 2022; 10():876430. PubMed ID: 36249247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of the observed high prevalence of loss to follow-up in ART-experienced adult PLHIV: a retrospective longitudinal cohort study in the Tanga Region, Tanzania.
    Mushy SE; Mtisi E; Mboggo E; Mkawe S; Yahya-Malima KI; Ndega J; Ngalesoni F; Muya A
    BMC Infect Dis; 2023 Feb; 23(1):92. PubMed ID: 36788523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postnatal retention in HIV care: insight from the Swiss HIV Cohort Study over a 15-year observational period.
    Aebi-Popp K; Kouyos R; Bertisch B; Staehelin C; Rudin C; Hoesli I; Stoeckle M; Bernasconi E; Cavassini M; Grawe C; Lecompte TD; Rickenbach M; Thorne C; Martinez de Tejada B; Fehr J; ;
    HIV Med; 2016 Apr; 17(4):280-8. PubMed ID: 26268702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tracing People Living With Human Immunodeficiency Virus Who Are Lost to Follow-up at Antiretroviral Therapy Programs in Southern Africa: A Sampling-Based Cohort Study in 6 Countries.
    Ballif M; Christ B; Anderegg N; Chammartin F; Muhairwe J; Jefferys L; Hector J; van Dijk J; Vinikoor MJ; van Lettow M; Chimbetete C; Phiri SJ; Onoya D; Fox MP; Egger M
    Clin Infect Dis; 2022 Jan; 74(2):171-179. PubMed ID: 33993219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss to follow-up among youth accessing outpatient HIV care and treatment services in Kisumu, Kenya.
    Ojwang' VO; Penner J; Blat C; Agot K; Bukusi EA; Cohen CR
    AIDS Care; 2016; 28(4):500-7. PubMed ID: 26565428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality and loss to follow-up in the first year of ART: Malawi national ART programme.
    Weigel R; Estill J; Egger M; Harries AD; Makombe S; Tweya H; Jahn A; Keiser O
    AIDS; 2012 Jan; 26(3):365-73. PubMed ID: 22095194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virologic non-suppression and early loss to follow up among pregnant and non-pregnant adolescents aged 15-19 years initiating antiretroviral therapy in South Africa: a retrospective cohort study.
    Nyakato P; Schomaker M; Fatti G; Tanser F; Euvrard J; Sipambo N; Fox MP; Haas AD; Yiannoutsos CT; Davies MA; Cornell M
    J Int AIDS Soc; 2022 Jan; 25(1):e25870. PubMed ID: 35032096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiretroviral therapy uptake and predictors of virological failure in patients with HIV receiving first-line and second-line regimens in Johannesburg, South Africa: a retrospective cohort data analysis.
    Gumede SB; Venter F; de Wit J; Wensing A; Lalla-Edward ST
    BMJ Open; 2022 Apr; 12(4):e054019. PubMed ID: 35428623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of loss to follow-up in patients on antiretroviral treatment, South Africa, 2004-2012: a cohort study.
    Mberi MN; Kuonza LR; Dube NM; Nattey C; Manda S; Summers R
    BMC Health Serv Res; 2015 Jul; 15():259. PubMed ID: 26141729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss to follow-up and mortality among HIV-infected adolescents receiving antiretroviral therapy in Pune, India.
    Nimkar S; Valvi C; Kadam D; Rewari BB; Kinikar A; Gupte N; Suryavanshi N; Deluca A; Shankar A; Golub J; Bollinger R; Gupta A; Marbaniang I; Mave V
    HIV Med; 2018 Jul; 19(6):395-402. PubMed ID: 29573312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of loss to follow-up among children in the first and second years of antiretroviral treatment in Johannesburg, South Africa.
    Sengayi M; Dwane N; Marinda E; Sipambo N; Fairlie L; Moultrie H
    Glob Health Action; 2013 Jan; 6():19248. PubMed ID: 23364098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of loss to follow-up from HIV antiretroviral therapy in Namibia.
    Hong SY; Winston A; Mutenda N; Hamunime N; Roy T; Wanke C; Tang AM; Jordan MR
    PLoS One; 2022; 17(4):e0266438. PubMed ID: 35421126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.